MeVis Medical Solutions AGFRA:M3V +1.72%66 Current Ratio is 2.27 as of Mar. 2026, which is 26% above its 10-year median of 1.80. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 69.16% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. MeVis Medical Solutions AG's current ratio for the quarter that ended in Mar. 2026 was 2.27.
MeVis Medical Solutions AG has a current ratio of 2.27. It generally indicates good short-term financial strength.
The historical rank and industry rank for MeVis Medical Solutions AG's Current Ratio or its related term are showing as below:
FRA:M3V'
s Current Ratio Range Over the Past 10 Years
Min: 1.48 Med: 1.8 Max: 3.9
Current: 2.27
During the past 13 years, MeVis Medical Solutions AG's highest Current Ratio was 3.90. The lowest was 1.48. And the median was 1.80.
FRA:M3V's Current Ratio is ranked better than 69.16% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs FRA:M3V: 2.27
MeVis Medical Solutions AG (FRA:M3V) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
MeVis Medical Solutions AG Current Ratio Related Terms
MeVis Medical Solutions AG Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3V vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Current Ratio distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG (FRA:M3V) has a Current Ratio of 2.27 as of Mar. 2026. This is 26% above median its historical median of 1.80. Over the past decade, MeVis Medical Solutions AG's Current Ratio has ranged from 1.48 to 3.90. According to the industry distribution chart, MeVis Medical Solutions AG ranks #210 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 30.8%.
Is MeVis Medical Solutions AG's Current Ratio too high?
MeVis Medical Solutions AG's current Current Ratio of 2.27 is 26% above median its 10-year median of 1.80. Over the past 10 years, this metric has ranged from a low of 1.48 to a high of 3.90. The Healthcare Providers & Services industry median Current Ratio is 1.47. MeVis Medical Solutions AG's value of 2.27 is 54.4% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #210 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #210 out of 681 companies for Current Ratio. This puts MeVis Medical Solutions AG in the upper half of its industry. The industry median Current Ratio is 1.47. MeVis Medical Solutions AG's value of 2.27 is 54.4% above this benchmark. Historically, MeVis Medical Solutions AG's own Current Ratio has ranged from 1.48 to 3.90 over the past decade. While the company's 10-year median is 1.80 vs. the industry median of 1.47, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current Current Ratio of 2.27 is 54.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Current Ratio is 2.27, which is 26% above median its own 10-year median of 1.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Current Ratio of 2.27. The stock's GF Value™ is €22.52, compared to a current price of €23.60 — trading 4.8% above its estimated fair value. The current Current Ratio is 2.27, which is 26% above median its 10-year median of 1.80 and 54.4% above the Healthcare Providers & Services industry median of 1.47. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Current Ratio is 2.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.60 is trading 4.8% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
Current Ratio: 2.27 (26% above median its 10-year median of 1.80)
GF Value™: €22.52 vs. price of €23.60 (4.8% above fair value)
Industry Position: 54.4% above the Healthcare Providers & Services median (#210 of 681)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
